Best Practices in PET/CT: Consensus on Performance of Positron Emission Tomography-Computed Tomography

Seminars in Ultrasound, CT and MRI

Volumn 29, Issue 4, 2008, Pages 236-241

  Blodgett, Todd ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; CANCER DIAGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONSENSUS DEVELOPMENT; DIAGNOSTIC ACCURACY; GOLD STANDARD; ONCOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

HUMANS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 49049119683     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sult.2008.05.007     Document Type: Article

References (32)

1. Townsend D.W. Combined positron emission tomography-computed tomography: the historical perspective. Semin Ultrasound CT MR 29 (2008) 232-235
2. Brink J.A. PET/CT unplugged: the merging technologies of PET and CT imaging. AJR Am J Roentgenol 184 (2005) S135-S137
3. Blodgett T.M., Casagranda B., and Townsend D.W. Issues, controversies, and clinical utility of combined PET/CT imaging: what is the interpreting physician facing?. AJR Am J Roentgenol 184 (2005) S138-S145
4. Shreve P. Establishing a PET/CT Practice. AJR Am J Roentgenol 184 (2005) S146-S151
5. Halliday S., and Thrall J.H. The business of PET/CT. AJR Am J Roentgenol 148 (2005) S152-S155
6. Faasse T., and Shreve P. Positron emission tomography-computed tomography patient management and workflow. Semin Ultrasound CT MR 29 (2008) 277-282
7. Zhuang H., Pourdehnad M., Lambright E.S., et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42 (2001) 1412-1417
8. Matthies A., Hickeson M., Cuchiara A., et al. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 43 (2002) 871-875
9. Xiu Y., Bhutani C., Dhurairaj T., et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med 32 (2007) 101-105
10. Alkhawaldeh K., Bural G., and Kumar R. Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 35 (2008) 246-252
11. Zytoon AA, Murakami K, El-Kholy MR: Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT. Eur J Radiol (in press)
12. Sahlmann C.O., Siefker U., and Lehmann K. Dual time point 2-[18F]fluoro-2′-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis. Nucl Med Commun 25 (2004) 819-823
13. Yen R.F., Chen K.C., Lee J.M., et al. (18)F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?. Eur J Nucl Med Mol Imaging 35 (2008) 1305-1315
14. Chen Y.M., Huang G., Sun X.G., et al. Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan. Nucl Med Commun 29 (2008) 425-430
15. Cohade C., Osman M., Pannu H.K., et al. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. J Nucl Med 44 (2003) 170-176
16. Yeung H.W., Grewal R.K., and Gonen M. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 44 (2003) 1789-1796
17. Truong M.T., Erasmus J.J., Munden R.F., et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR Am J Roentgenol 183 (2004) 1127-1132
18. Rousseau C., Bourbouloux E., Campion L., et al. Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET/CT scans. Eur J Nucl Med Mol Imaging 33 (2006) 785-791
19. Cohade C., Mourtzikos K.A., and Wahl R.L. "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med 44 (2003) 1267-1270
20. Tatsumi M., Engles J.M., Ishimori T., et al. Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 45 (2004) 1189-1193
21. Williams G., and Kolodny G.M. Method for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PET. AJR Am J Roentgenol 190 (2008) 1406-1409
22. Frush D.P., and Applegate K. Computed tomography and radiation: understanding the issues. J Am Coll Radiol 1 (2004) 113-119
23. Brenner D.J., and Hall E.J. Computed tomography-an increasing source of radiation exposure. N Engl J Med 357 (2007) 2277-2284
24. Keyes J.W. SUV: standardized uptake or silly useless value?. J Nucl Med 36 (1995) 1836-1839
25. Aquino S.L., and Fishman A.J. Does whole-body 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?. Chest 126 (2004) 744-760
26. Wartski M., Le Stanc E., Gontier E., et al. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun 28 (2007) 365-371
27. Kuehl H., Veit P., Rosenbaum S.J., et al. Can PET/CT replace separate diagnostic CT for cancer imaging?. Optimizing CT protocols for imaging cancer of the chest and abdomen. J Nucl Med 48 (2007) S45-S57
28. Pfannenberg A.C., Aschoff P., and Brechtel K. Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncologic imaging. Br J Radiol 80 (2007) 437-445
29. Soyka J.D., Veit-Haibach P., and Strobel K. Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?. J Nucl Med 49 (2008) 3354-3361
30. Yau Y.Y., Chan W.S., Tam Y.M., et al. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?. J Nucl Med 46 (2005) 283-291
31. Berthelsen A.K., Holm S., Loft A., et al. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 32 (2005) 1167-1175
32. Mawlawi O., Erasmus J.J., Munden R.F., et al. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. AJR Am J Roentgenol 186 (2006) 308-319